Tay Sachs Disease (Credo)Tay-Sachs disease (TSD) is the best known of the sphingolipidoses, a group of genetic disorders including Niemann-Pick disease, Gaucher’s disease, and others. Specifically, TSD is GM2(beta) gangliosidosis. Affected individuals (recessive homozygotes) produce virtually no hexosaminidase A (hex A), an enzyme necessary for normal neurological development. TSD is rare in most populations but is about 100 times more prevalent among Ashkenazi Jews. This indicates that TSD gene frequency is about 10 times higher in the Ashkenazi population. Persons with TSD usually show symptoms of neurological degeneration by 6 months of age. Their condition steadily deteriorates, and they seldom live beyond age 4. There is no cure, but heterozygous “carriers” of the defective gene can be identified, and amniocentesis can detect an affected fetus.